3-hydroxyacyl-coenzyme A dehydrogenase deficiency

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
3-hydroxyacyl-coenzyme A dehydrogenase deficiency
Classification and external resources
ICD-10 GroupMajor.minor
ICD-9 xxx
OMIM 601609 231530
DiseasesDB 34396

WikiDoc Resources for

3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Articles

Most recent articles on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Most cited articles on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Review articles on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Articles on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Images of 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Photos of 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Podcasts & MP3s on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Videos on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Evidence Based Medicine

Cochrane Collaboration on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Bandolier on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

TRIP on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Clinical Trials

Ongoing Trials on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency at Clinical Trials.gov

Trial results on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Clinical Trials on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

NICE Guidance on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

NHS PRODIGY Guidance

FDA on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

CDC on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Books

Books on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

News

3-hydroxyacyl-coenzyme A dehydrogenase deficiency in the news

Be alerted to news on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

News trends on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Commentary

Blogs on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Definitions

Definitions of 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Patient Resources / Community

Patient resources on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Discussion groups on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Patient Handouts on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Directions to Hospitals Treating 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Risk calculators and risk factors for 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Healthcare Provider Resources

Symptoms of 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Causes & Risk Factors for 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Diagnostic studies for 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Treatment of 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Continuing Medical Education (CME)

CME Programs on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

International

3-hydroxyacyl-coenzyme A dehydrogenase deficiency en Espanol

3-hydroxyacyl-coenzyme A dehydrogenase deficiency en Francais

Businness

3-hydroxyacyl-coenzyme A dehydrogenase deficiency in the Marketplace

Patents on 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Experimental / Informatics

List of terms related to 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

3-hydroxyacyl-coenzyme A dehydrogenase deficiency (HADH deficiency) is a rare condition that prevents the body from converting certain fats to energy, particularly during fasting. Normally, through a process called fatty acid oxidation, several enzymes work in a step-wise fashion to metabolize fats and convert them to energy. People with 3-hydroxyacyl-coenzyme A dehydrogenase deficiency have inadequate levels of an enzyme required for a step that metabolizes groups of fats called medium-chain fatty acids and short-chain fatty acids; for this reason this disorder is sometimes called medium- and short-chain 3-hydroxyacyl-coenzyme A dehydrogenase (M/SCHAD) deficiency.

Typically, initial signs and symptoms of this disorder occur during infancy or early childhood and can include poor appetite, vomiting, diarrhea, lethargy, hypoglycemia, hypotonia, liver problems, and abnormally high levels of hyperinsulinism. Insulin controls the amount of sugar that moves from the blood into cells for conversion to energy. Individuals with 3-hydroxyacyl-coenzyme A dehydrogenase deficiency are also at risk for complications such as seizures, life-threatening heart and breathing problems, coma, and sudden unexpected death.

Problems related to 3-hydroxyacyl-coenzyme A dehydrogenase deficiency can be triggered by periods of fasting or by illnesses such as viral infections. This disorder is sometimes mistaken for Reye syndrome, a severe disorder that may develop in children while they appear to be recovering from viral infections such as chicken pox or flu. Most cases of Reye syndrome are associated with the use of aspirin during these viral infections.

Mutations in the HADH gene lead to inadequate levels of an enzyme called 3-hydroxyacyl-coenzyme A dehydrogenase. Medium-chain and short-chain fatty acids cannot be metabolized and processed properly without sufficient levels of this enzyme. As a result, these fatty acids are not converted to energy, which can lead to characteristic features of this disorder, such as lethargy and hypoglycemia. Medium-chain and short-chain fatty acids or partially metabolized fatty acids may build up in tissues and damage the liver, heart, and muscles, causing more serious complications.

This condition is inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. Most often, the parents of an individual with an autosomal recessive disorder each carry one copy of the altered gene but do not show signs and symptoms of the disorder.

See also

References

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools